Evaluation of efficacies of different classes of antidepressants in the forced swimming test in mice at different ages

被引:52
作者
Bourin, M [1 ]
Colombel, MC
Redrobe, JP
Nizard, J
Hascoet, M
Baker, GB
机构
[1] Fac Med, Dept Pharmacol, GIS Medicament, Pharmacol Lab, F-44035 Nantes 01, France
[2] Univ Alberta, Dept Psychiat, Neurochem Res Unit, Edmonton, AB T6G 2M7, Canada
关键词
aged mice; antidepressants; forced swimming test; 5 HT1B receptors;
D O I
10.1016/S0278-5846(98)00009-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
1. The efficacies of different classes of antidepressants were investigated using the forced swimming test with mice at different ages. 2. Imipramine (4-32 mg/kg), desipramine (2-16 mg/kg) and bupropion (32, 64 mg/kg) showed activity in all age groups. 3. The selective serotonin reuptake inhibitors (SSRIs) citalopram (16 and 32 mg) and paroxetine (4 and 8 mg) were inactive in the oldest (40 weeks) group of mice, despite showing activity at the same doses in mice ranging in age from 4-24 weeks old. 4. Both SSRIs showed anti-immobility effects at low doses, (paroxetine: 1 and 2 mg/kg; citalopram: 4 and 8 mg/kg) in the 40-week old mice. These effects were not evident in the three younger groups of mice. 5.Moclobemide, a reversible selective inhibitor of monoamine oxidase-A, showed activity only at a high dose (128 mg/kg) and only in 12-week old animals. 6. Since SSRIs have been reported to have relatively selective effects on 5-HT1B receptors, the present results suggest that further studies comparing the effectiveness of SSRIs and other antidepressants in elderly patients should be done, Studies of the effects of aging on the density and/or affinity of 5-HT1A and 5-HT1B/1D receptors are also warranted.
引用
收藏
页码:343 / 351
页数:9
相关论文
共 37 条
[1]  
Allain H, 1995, MOL BASIS AGING, P511
[2]  
[Anonymous], TXB PSYCHOPHARMACOLO
[3]  
BORSINI F, 1988, PSYCHOPHARMACOLOGY, V94, P147
[4]   EVIDENCE OF DOPAMINE INVOLVEMENT IN THE EFFECT OF REPEATED TREATMENT WITH VARIOUS ANTIDEPRESSANTS IN THE BEHAVIORAL DESPAIR TEST IN RATS [J].
BORSINI, F ;
PULVIRENTI, L ;
SAMANIN, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 110 (02) :253-256
[5]  
BOURIN M, 1992, NEW PROSPECTS PSYCHI, P161
[6]   ANIMAL-MODELS FOR ANXIETY AND RESPONSE TO SEROTONERGIC DRUGS [J].
BROEKKAMP, CLE ;
BERENDSEN, HHG ;
JENCK, F ;
VANDELFT, AML .
PSYCHOPATHOLOGY, 1989, 22 :2-12
[7]   AGE-RELATED-CHANGES IN RAT SEROTONERGIC AND ADRENERGIC SYSTEMS AND IN RECEPTOR RESPONSIVENESS TO SUBCHRONIC DESIPRAMINE TREATMENT [J].
BRUNELLO, N ;
RIVA, M ;
ROVESCALLI, AC ;
GALIMBERTI, R ;
RACAGNI, G .
PHARMACOLOGY & TOXICOLOGY, 1988, 63 (03) :150-155
[8]   ROLE OF CENTRAL SEROTONERGIC NEURONS IN THE EFFECT OF SERTRALINE IN RATS IN THE FORCED SWIMMING TEST [J].
CERVO, L ;
GRIGNASCHI, G ;
ROSSI, C ;
SAMANIN, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 196 (03) :217-222
[9]   AGING ASSOCIATED CHANGES IN SEROTONINERGIC AND DOPAMINERGIC PRESYNAPTIC AND POSTSYNAPTIC NEUROCHEMICAL MARKERS IN THE RAT-BRAIN [J].
GOZLAN, H ;
DAVAL, G ;
VERGE, D ;
SPAMPINATO, U ;
FATTACCINI, CM ;
GALLISSOT, MC ;
ELMESTIKAWY, S ;
HAMON, M .
NEUROBIOLOGY OF AGING, 1990, 11 (04) :437-449
[10]   DISTINCT 5-HT(1B) AND 5-HT(1D) SEROTONIN RECEPTORS IN RAT - STRUCTURAL AND PHARMACOLOGICAL COMPARISON OF THE 2 CLONED RECEPTORS [J].
HAMBLIN, MW ;
MCGUFFIN, RW ;
METCALF, MA ;
DORSA, DM ;
MERCHANT, KM .
MOLECULAR AND CELLULAR NEUROSCIENCE, 1992, 3 (06) :578-587